Omeprazole magnesium and Hepatic function abnormal - a phase IV clinical study of FDA data
Summary:
Hepatic function abnormal is reported as a side effect among people who take Omeprazole magnesium (omeprazole magnesium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Dexamethasone Acetate, and have Lung cancer - non-small cell.
The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Omeprazole magnesium. It is created by eHealthMe based on reports of 6,837 people who have side effects when taking Omeprazole magnesium from the FDA, and is updated regularly.
What is Omeprazole magnesium?
Omeprazole magnesium has active ingredients of omeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,956 Omeprazole magnesium users. Check the latest studies of Omeprazole magnesium.
What is Hepatic function abnormal?
Hepatic function abnormal is found to be associated with 1,435 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
6,837 people reported to have side effects when taking Omeprazole magnesium.
Among them, 18 people (0.26%) have Hepatic function abnormal.

Among these 18 people:
How long have people been on Omeprazole magnesium when they have Hepatic function abnormal? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hepatic function abnormal when taking Omeprazole magnesium? *
- female: 38.89 %
- male: 61.11 %
What is the age of people who have Hepatic function abnormal when taking Omeprazole magnesium? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 35.29 %
- 40-49: 35.29 %
- 50-59: 0.0 %
- 60+: 29.41 %
What are other drugs people take besides Omeprazole magnesium? *
- Dexamethasone Acetate: 16 people, 88.89%
- Betamethasone Sodium Phosphate: 7 people, 38.89%
- Lansoprazole: 6 people, 33.33%
- Carboplatin: 6 people, 33.33%
- Dexamethasone Sodium Phosphate: 6 people, 33.33%
- Pemetrexed: 6 people, 33.33%
- Folic Acid: 6 people, 33.33%
- Ondansetron Hydrochloride: 6 people, 33.33%
- Glutathione: 6 people, 33.33%
- Loperamide Hydrochloride: 4 people, 22.22%
What are other side effects people have besides Hepatic function abnormal? *
- Insomnia (sleeplessness): 4 people, 22.22%
- Indigestion: 4 people, 22.22%
- Hypokalemia (low potassium): 4 people, 22.22%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 22.22%
- Dry Eyes (lack of adequate tears): 4 people, 22.22%
- Diarrhea: 4 people, 22.22%
- Myelosuppression (a decrease in the production of blood cells): 3 people, 16.67%
- Liver Injury: 3 people, 16.67%
- Immunodeficiency: 3 people, 16.67%
- Hyperglycemia (high blood sugar): 3 people, 16.67%
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 9 people, 50.00%
- Rashes (redness): 6 people, 33.33%
- Resorption Bone Increased: 4 people, 22.22%
- Pneumonia: 4 people, 22.22%
- Osteoporosis (bones weak and more likely to break): 4 people, 22.22%
- Non-Small Cell Lung Cancer Stage Iv: 4 people, 22.22%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 22.22%
- Immune System Disorder: 4 people, 22.22%
- Diarrhea: 4 people, 22.22%
- Back Pain: 4 people, 22.22%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole magnesium and have Hepatic function abnormal?
- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Omeprazole magnesium:
- Omeprazole magnesium (6,956 reports)
Hepatic function abnormal treatments and more:
- Hepatic function abnormal (47,051 reports)
How severe was Hepatic function abnormal and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole magnesium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omeprazole magnesium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hepatic function abnormal:
- Hepatic function abnormal (1,435 drugs)
Browse all the conditions that are associated with Hepatic function abnormal:
- Hepatic function abnormal (2,021 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole magnesium (the active ingredients of Omeprazole magnesium) and Omeprazole magnesium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Divalproex Sodium cause Head Injury? - 2 seconds ago
- Could Divalproex Sodium cause Dizziness? - 2 seconds ago
- Drug interactions of Trintellix and Xopenex Hfa - 4 seconds ago
- Could Ceftriaxone cause Vulvovaginal Dryness? - 17 seconds ago
- Could Profen cause Peripheral Swelling? - 18 seconds ago
- Could Diphen cause Hip Joint Replacement? - 23 seconds ago
- Could Ezetimibe cause Arthropathy? - 23 seconds ago
- Drug interactions of Chlor-Trimeton and Ibuprofen - 24 seconds ago
- Could Diphen cause Haemophilus Infection? - 24 seconds ago
- Could Diphen cause Diabetes Insipidus? - 32 seconds ago